Unlike constitutive TERT overexpression by transgenesis leading to cardiac hypertrophy [24], AAV9-mediated TERT transfer did not produce any signs of hypertrophy at 9 to 10 weeks post treatment. The gene discussed is TERT; the disease is cardiac hypertrophy.